US equities |
MU $878.84 ▼-5.63% NVDA $214.13 ▼-1.43% TSLA $354.72 ▼-2.13% AAPL $343.46 ▲+0.43% META $709.33 ▼-3.72% MSFT $529.05 ▼-1.93% SPCX $146.03 ▼-1.74% AMD $528.75 ▼-5.95%
FinancialContent

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

99.70 -0.29 (-0.29%)
Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
24 25 Next >
News headline image
4 Analysts Assess Lantheus Holdings: What You Need To Know ↗
 
Via Benzinga
News headline image
LNTH Q2 Deep Dive: Competitive Pressures and Guidance Cut Reshape Lantheus Outlook
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 4.1% year on year to $378 million. The company’s full-year revenue... 
Via StockStory
News headline image
Lantheus (LNTH) Q2 Revenue Falls 4% ↗
Via The Motley Fool
News headline image
What's going on in today's session ↗
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
Earnings Scheduled For August 6, 2025 ↗
 
Via Benzinga
News headline image
What Does the Market Think About Lantheus Holdings? ↗
 
Via Benzinga
News headline image
Nasdaq Surges 1%; Uber Sales Top Estimates ↗
 
Via Benzinga
News headline image
Why Lantheus (LNTH) Stock Is Falling Today
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 29.8% in the afternoon session after the company reported disappointing second-quarter financial results and slashed its... 
Via StockStory
Topics Lawsuit
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Here are the top movers in Wednesday's session. ↗
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
The market is filled with gapping stocks in Wednesday's session. ↗
Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill
News headline image
US Stocks Edge Higher; McDonald's Posts Upbeat Earnings ↗
 
Via Benzinga
News headline image
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) Shares Plunge 20.8% After Q2 2025 Earnings Miss and Weak Guidance ↗
Lantheus Holdings (LNTH) Q2 2025 earnings miss estimates, revenue down 4.1%. Shares drop 20.8% as weak guidance raises concerns. FDA accepts NDA for PYLARIFY upgrade. 
Via Chartmill
Topics Earnings
News headline image
Discover the top movers in Wednesday's pre-market session. ↗
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Lantheus (NASDAQ:LNTH) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops 20.8%
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling 4.1% year on year to $378 million. The company’s full-year... 
Via StockStory
News headline image
Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus (LNTH) Reports Q2: Everything You Need To Know Ahead Of Earnings
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings this Wednesday before market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence Government World Trade
News headline image
LANTHEUS HOLDINGS INC (NASDAQ:LNTH): A Prime Value Investment with Strong Fundamentals ↗
Lantheus Holdings (LNTH) is a standout value stock with strong financials, low P/E ratios, and high profitability, making it an attractive pick for value investors. 
Via Chartmill
News headline image
Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit World Trade
News headline image
Why Is Lantheus Stock Trading Lower On Wednesday? ↗
CMS proposes a $140 drug packaging threshold and a $655 diagnostic radiopharmaceutical threshold for CY 2026, using inflation-adjusted PPI data. 
Via Benzinga
News headline image
Why Lantheus (LNTH) Stock Is Down Today
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 7.7% in the morning session after the stock hit a new 52-week low amid persistent investor concerns over rising competition... 
Via StockStory
Topics ETFs Stocks World Trade
News headline image
Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
News headline image
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) – An Undervalued Stock with Strong Fundamentals ↗
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is an undervalued healthcare stock with strong profitability, financial health, and reasonable growth potential, making it a candidate for value investors. 
Via Chartmill
News headline image
Spotting Winners: Lantheus (NASDAQ:LNTH) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q1
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Lantheus (NASDAQ:LNTH) and the best and... 
Via StockStory
Topics Artificial Intelligence
News headline image
Shuttle Pharma Ramps Up Fight Against Glioblastoma With New Leadership, Promising Clinical Trial, and Bold Innovations ↗
Via Stocktwits
Topics Cannabis
News headline image
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) – An Undervalued Stock With Strong Fundamentals ↗
Lantheus Holdings (NASDAQ:LNTH) presents an undervalued opportunity with strong profitability, financial health, and reasonable growth, making it a candidate for value investors. 
Via Chartmill
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
24 25 Next >